Hiking in a slot canyon wearing a plaid flannel shirt is a symptom of having moderate to severe rheumatoid arthritis.

They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...

The widely used class of drugs, called SGLT2 inhibitors and sold under brand names such as Jardiance and Farxiga, have been on the market for over a decade as Type 2 diabetes medications.

This hideous commercial for Jardiance features a deranged woman who is so deliriously ... the Director of Chemical and Pharmaceutical Science, comes from the world of drug discovery, where he did ...

During a study, people who consumed Jardiance alone or with other diabetes medicines lost between 1.8 and 3.2 percent of their body weight. This weight loss was noticed in 24 weeks, according to ...

Trump is correct. Too many drug prices are too high. Here's how pharmacy benefit managers help inflate the prices of drugs in ...

The new approval comes shortly after Jardiance became the first SGLT2 drug to be approved by the FDA in children 10 years and older with type 2 diabetes. Image. Phil Taylor. 25 July, 2023.

Eli Lilly and Company (NYSE:LLY) is one of the 12 stocks that will make you rich in 10 years. On June 23, Truist Securities ...

Boehringer and Eli Lilly have moved closer to a heart failure indication for their SGLT2 inhibitor Jardiance, as the FDA starts a fast-track review of the drug in its first use beyond diabetes.

Megablockbusters are on the rise in pharma. More drugs are surpassing the $10 billion sales threshold than ever before, ...

TOKYO -- German drugmaker Boehringer Ingelheim plans to invest a total of 300 million euros ($346 million) in its plant in Japan from 2023 to 2028 as it moves to make the facility a production base ...